Global Preclinical Imaging Market Report 2024

Preclinical Imaging Global Market Report 2024 – By Modality (Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems), By Reagents (Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents ), By End User (Hospital, Diagnostics Center, Other End-User) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Preclinical Imaging Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN

Preclinical Imaging Market Definition And Segments

Preclinical imaging refers to the techniques used to visualize and study biological processes in animal models before being applied to human clinical trials. These imaging techniques allow researchers to track disease progression, evaluate the efficacy and safety of potential therapeutics, and gain insights into the biological mechanisms underlying diseases.

The main types of modalities in preclinical imaging are optical imaging systems, preclinical nuclear imaging systems, micro-magnetic resonance imaging systems, micro-ultrasound systems, micro-computed tomography systems, preclinical photoacoustic imaging systems, and preclinical magnetic particle imaging (MPI) systems. Optical imaging systems refer to a range of imaging technologies that utilize light to visualize and capture images of biological tissues, cells, or molecules. Optical imaging systems are employed in the preclinical phase of imaging for research, illness diagnostics, tumor blood vessel growth monitoring, and tissue blood oxygenation tracking in animals. It includes various reagents such as preclinical optical imaging reagents, preclinical nuclear imaging reagents, preclinical MRI contrast agents, preclinical ultrasound contrast agents and preclinical CT contrast agents. The main end-users are hospitals, diagnostic centers, and others.

The preclinical imaging market covered in this report is segmented –

1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

3) By End User: Hospital, Diagnostics Center, Other End-User

The preclinical imaging market size has grown strongly in recent years. It will grow from $3.2 billion in 2023 to $3.44 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to government initiatives, the growing prevalence of diseases, expanding applications, increasing awareness, and emerging markets expansion.

The preclinical imaging market size is expected to see strong growth in the next few years. It will grow to $4.42 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to personalized medicine adoption, advancements in molecular imaging, drug development outsourcing, regulatory support, and rising chronic diseases. Major trends in the forecast period include green imaging technologies, technological advancements, a rise in R&D activities, collaborations and partnerships, and real-time imaging.

Rising Chronic Disease Burden Fuels Preclinical Imaging Market Growth

The increase in chronic diseases is expected to propel the growth of the preclinical imaging market going forward. Chronic diseases refer to long-term health conditions that persist for an extended period, typically lasting for three months or more. These diseases often require ongoing medical management and can significantly impact a person's quality of life. For identifying chronic diseases, preclinical imaging tools are used for visualizing the bone structure and lung function. It is also used to study chronic diseases to visualize the progression of the disease and improve disease understanding. For instance, in September 2022, according to the World Health Organization (WHO) 2022 Highlights, a Switzerland-based intergovernmental health organization, there were 41 million deaths, which is 74% of all deaths caused by Noncommunicable diseases (NCDs) or chronic diseases every year globally. Among them are 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Therefore, increasing chronic disease is driving the growth of the preclinical imaging market.

Pharmaceutical Boom Fuels Preclinical Imaging Market Growth

Rising demand for pharmaceutical products is expected to propel the growth of the preclinical imaging market going forward. Pharmaceutical products refer to substances or compounds formulated and manufactured to prevent, diagnose, or treat medical conditions. Preclinical imaging in the pharmaceutical industry enhances decision-making by providing valuable insights into drug efficacy, safety, and mechanisms of action before advancing to clinical trials. For instance, in April 2023, according to Eurostat, a Luxembourg-based government agency, exports of medicinal and pharmaceutical products increased to $307 billion (€287) billion in 2022, an increase of 22% from a year earlier. Additionally, imports rose from $107 billion (€100 billion) in 2021 to $120 billion (€112 billion) in 2022. Furthermore, in February 2023, according to the Merck Group, a Germany-based pharmaceutical company, pharmaceutical product sales for the year 2022 accounted for $59.3 billion, a 22% increase over the full year 2021. Therefore, rising demand for pharmaceutical products is driving the growth of the preclinical imaging market.

Major companies operating in the preclinical imaging market report are Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, EKF Diagnostics Holdings plc., Piramal Enterprises Ltd., LI-COR Biosciences Inc., Aspect Imaging Ltd., Capintec Inc., Spectral Instruments Inc., Mediso Ltd., MR Solutions Ltd., Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics.

Revolutionizing Preclinical Imaging Through Cutting-Edge Technology And Flexibility

Product innovations are a key trend gaining popularity in the preclinical imaging market. Major companies operating in the preclinical imaging market are developing innovative products to sustain their position in the market. For instance, in May 2022, Fujifilm VisualSonics Inc., a Canada-based biomedical company that manufactures imaging systems, launched Vevo F2 for preclinical imaging. This innovative product is the first preclinical ultra-high- to low-frequency (71 MHz–1 MHz) ultrasonic and photoacoustic imaging system. The Vevo F2 features HD image processing technology and a completely new signal pathway, enabling better image clarity and better frame rates. The system is also customizable to fit the specific precision demands of imaging. Additionally, it includes features such as HD image processing technology, a completely new signal pathway, customizable system architecture, a wide range of anatomical targets, and high-resolution imaging. It is suitable for a variety of research applications.

Next-Generation Imaging Systems For Enhanced Capabilities And Workflow Efficiency

Major companies operating in the preclinical imaging market are increasing their focus on introducing next-generation imaging systems to gain a competitive edge in the market. Next-generation imaging systems refer to advanced and innovative technologies that go beyond current capabilities, incorporating cutting-edge features. For instance, in September 2023, Revvity Inc., a US-based biotechnology company, launched next-generation imaging systems that are designed to drive innovation across diverse applications in preclinical research. The newly launched products include the next-generation IVIS Spectrum 2 and the IVIS SpectrumCT 2 imaging systems, the Quantum GX3 microCT imaging solution, and a system that seamlessly integrates 2D optical and full 3D imaging. These imaging systems feature improved image-based capabilities and are designed to streamline the imaging workflow.

Rigaku Corporation Expands Preclinical Imaging Portfolio With Acquisition Of Milabs B.V.

In August 2021, Rigaku Corporation, a Japan-based X-ray technology manufacturing company, acquired MILabs B.V. for an undisclosed amount. With this acquisition, Rigaku Corporation aims to expand its presence in the life sciences market, strengthen its research and development capabilities for its product portfolio, and gain access to MILabs' technology and expertise. MILabs B.V. is a Netherlands-based manufacturer of preclinical imaging systems intended for universities, biomedical research, and pharmaceutical research.

North America was the largest region in the preclinical imaging market in 2023. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the preclinical imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The preclinical imaging market includes of revenues earned by entities by providing preclinical imaging services such as magnetic resonance imaging, positron emission tomography, computed tomography, and optical imaging services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The preclinical imaging market research report is one of a series of new reports from The Business Research Company that provides preclinical imaging market statistics, including preclinical imaging industry global market size, regional shares, competitors with a preclinical imaging market share, detailed preclinical imaging market segments, market trends and opportunities, and any further data you may need to thrive in the preclinical imaging industry. This preclinical imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Preclinical Imaging Market Characteristics

    3. Preclinical Imaging Market Trends And Strategies

    4. Preclinical Imaging Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Preclinical Imaging Market Size and Growth

    5.1. Global Preclinical Imaging Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Preclinical Imaging Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Preclinical Imaging Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Preclinical Imaging Market Segmentation

    6.1. Global Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Optical Imaging Systems

    Preclinical Nuclear Imaging Systems

    Micro-magnetic Resonance Imaging Systems

    Micro-Ultrasound Systems

    Micro-computed Tomography Systems

    Preclinical Photoacoustic Imaging Systems

    Preclinical Magnetic Particle Imaging (MPI) Systems

    6.2. Global Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Preclinical Optical Imaging Reagents

    Preclinical Nuclear Imaging Reagents

    Preclinical MRI Contrast Agents

    Preclinical Ultrasound Contrast Agents

    Preclinical CT Contrast Agents

    6.3. Global Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital

    Diagnostics Center

    Other End-User

    7. Preclinical Imaging Market Regional And Country Analysis

    7.1. Global Preclinical Imaging Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Preclinical Imaging Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Preclinical Imaging Market

    8.1. Asia-Pacific Preclinical Imaging Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Preclinical Imaging Market

    9.1. China Preclinical Imaging Market Overview

    9.2. China Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Preclinical Imaging Market

    10.1. India Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Preclinical Imaging Market

    11.1. Japan Preclinical Imaging Market Overview

    11.2. Japan Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Preclinical Imaging Market

    12.1. Australia Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Preclinical Imaging Market

    13.1. Indonesia Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Preclinical Imaging Market

    14.1. South Korea Preclinical Imaging Market Overview

    14.2. South Korea Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Preclinical Imaging Market

    15.1. Western Europe Preclinical Imaging Market Overview

    15.2. Western Europe Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Preclinical Imaging Market

    16.1. UK Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Preclinical Imaging Market

    17.1. Germany Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Preclinical Imaging Market

    18.5. France Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Preclinical Imaging Market

    19.9. Italy Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Preclinical Imaging Market

    20.13. Spain Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Preclinical Imaging Market

    21.1. Eastern Europe Preclinical Imaging Market Overview

    21.2. Eastern Europe Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Preclinical Imaging Market

    22.1. Russia Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Preclinical Imaging Market

    23.1. North America Preclinical Imaging Market Overview

    23.2. North America Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Preclinical Imaging Market

    24.1. USA Preclinical Imaging Market Overview

    24.2. USA Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Preclinical Imaging Market

    25.1. Canada Preclinical Imaging Market Overview

    25.2. Canada Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Preclinical Imaging Market

    26.1. South America Preclinical Imaging Market Overview

    26.2. South America Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Preclinical Imaging Market

    27.1. Brazil Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Preclinical Imaging Market

    28.1. Middle East Preclinical Imaging Market Overview

    28.2. Middle East Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Preclinical Imaging Market

    29.1. Africa Preclinical Imaging Market Overview

    29.2. Africa Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Preclinical Imaging Market Competitive Landscape And Company Profiles

    30.1. Preclinical Imaging Market Competitive Landscape

    30.2. Preclinical Imaging Market Company Profiles

    30.2.1. Thermo Fisher Scientific Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. FUJIFILM Visualsonics Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Konica Minolta Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Agilent Technologies Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. PerkinElmer Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Preclinical Imaging Market Other Major And Innovative Companies

    31.1. Bio-Rad Laboratories Inc.

    31.2. Bruker Corporation

    31.3. Miltenyi Biotech

    31.4. Sofie Biosciences Inc.

    31.5. Promega Corporation

    31.6. Ion Beam Applications S.A

    31.7. Nihon Kohden

    31.8. EKF Diagnostics Holdings plc.

    31.9. Piramal Enterprises Ltd

    31.10. LI-COR Biosciences Inc.

    31.11. Aspect Imaging Ltd

    31.12. Capintec Inc.

    31.13. Spectral Instruments Inc.

    31.14. Mediso Ltd

    31.15. MR Solutions Ltd

    32. Global Preclinical Imaging Market Competitive Benchmarking

    33. Global Preclinical Imaging Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Preclinical Imaging Market

    35. Preclinical Imaging Market Future Outlook and Potential Analysis

    35.1 Preclinical Imaging Market In 2028 - Countries Offering Most New Opportunities

    35.2 Preclinical Imaging Market In 2028 - Segments Offering Most New Opportunities

    35.3 Preclinical Imaging Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Preclinical Imaging Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Preclinical Imaging Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Thermo Fisher Scientific Inc. Financial Performance
  • Table 75: FUJIFILM Visualsonics Inc. Financial Performance
  • Table 76: Konica Minolta Inc. Financial Performance
  • Table 77: Agilent Technologies Inc. Financial Performance
  • Table 78: PerkinElmer Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Preclinical Imaging Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Preclinical Imaging Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 75: FUJIFILM Visualsonics Inc. Financial Performance
  • Figure 76: Konica Minolta Inc. Financial Performance
  • Figure 77: Agilent Technologies Inc. Financial Performance
  • Figure 78: PerkinElmer Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report